Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $371.1800 (-0.49%) ($369.3000 - $375.0000) on Fri. Feb. 17, 2017. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.94% (three month average) | | RSI | 68 | | Latest Price | $371.1800(-0.49%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 0.6% a day on average for past five trading days. | | Weekly Trend | REGN advances 2.7% a week on average for past two weeks. | | Market Behavior | Growth stock rally for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(49%) XBI(44%) IVW(42%) QQQ(42%) | | Factors Impacting REGN price | REGN will decline at least -0.97% in a week (0% probabilities).
VIXM(-8%) UUP(-8%) TLT(-6%) TIP(-2%) SHY(-2%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.97% (StdDev 1.94%) | | Hourly BBV | 0 () | | Intraday Trend | -0.3% | | | | | |
|
| 5 Day Moving Average | $376.08(-1.3%) | | 10 Day Moving Average | $367.77(0.93%) | | 20 Day Moving Average | $360.52(2.96%) | | To recent high | -8.5% | | To recent low | 8.9% | | Market Cap | $39.356b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |